FDA Inspection 1137610 — Suzhou Fushilai Pharmaceutical Co., Ltd.
The FDA completed an inspection of Suzhou Fushilai Pharmaceutical Co., Ltd. on March 26, 2021 in Changshu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 26, 2021
- Fiscal Year
- 2021
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Changshu (China)